Toronto Stock Exchange Symbol: DND
MISSISSAUGA, ON, July 17, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it
will host a conference call for its Q2 2013 financial results on
Wednesday, July 31, 2013.
Q2 2013 CONFERENCE CALL
WHEN: Wednesday, July 31, 2013 at 8:30AM ET
CONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450
or 1-888-231-8191. A live audio webcast will be available through http://www.cipherpharma.com or http://bit.ly/15IeDer. An archived replay of the webcast will be available for 365 days.
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: DND; OTC: CPHMF) is a growing specialty
pharmaceutical company with three commercial products and a fourth in
development. Our product candidates are typically improved formulations
of successful, currently marketed drugs. We in-license a product,
manage the required clinical development and regulatory approval
process, and either out-license it to a marketing partner, or, in
Canada, we may market the product ourselves. Our core capabilities are
in clinical and regulatory affairs, product licensing, supply chain
management, and marketing and sales. Since the Company was founded in
2000, we have achieved final regulatory approval in the U.S. and Canada
for all three of our original products and completed six marketing
partnerships, generating growing licensing revenue.
For more information, please visit www.cipherpharma.com.
SOURCE: Cipher Pharmaceuticals Inc.
For further information:
(416) 815-0700 ext 278
(416) 815-0080 fax
President and CEO
(905) 602-5840 ext 324
(905) 602-0628 fax